Remix Therapeutics to Present at 7th Annual Evercore HealthCONx Conference
Press Releases
Remix Therapeutics  
November 26, 2024

Remix Therapeutics to Present at 7th Annual Evercore HealthCONx Conference

CAMBRIDGE, Mass., Nov. 26, 2024 /PRNewswire/ -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today

logo salamanca press

Salamanca Press

Local & Social